II. Precautions
-
Insulin Dosing in the U.S. has become unconscionably expensive
- Consider NPH Insulin (still $25 per vial at Walmart as of 2016) for basal control instead
- Basal Insulin does not cover meal times
- Use in combination with agents to cover meals
- Rapid acting Insulin (e.g. Lispro)
- Oral agents (Sulfonylureas, Metformin, Glitazone) or
- Switch to basal/bolus when Glargine >0.5 units/kg
III. Medications: U-100
- Insulin Glargine U-100 (Lantus, Basaglar, Semglee)
- Information below is based on Lantus
- Most closely matches 24 hour coverage
- Semglee (Insulin Glargine-yfgn U-100) is considered interchangeable biosimilar to Lantus as of 2021 in U.S.
- Allows pharmacists to auto-substitute Semglee (one third Lantus cost) for Lantus
- (2021) Presc Lett 28(9): 51
- Insulin Degludec (Tresiba)
- Ultra Long acting Insulin (lasts 42 hours)
- Onset of activity in 90 minutes
- Available as U-100 or U-200
- Detemir U-100 (Levemir)
- Similar Pharmacokinetics as Lantus
- Less burning on injection compared with Lantus
- Binds and released from circulating albumin
- Most consistent basal Insulin day to day
- Duration varies by dose (twice daily may be preferred)
- Manufacturer discontinuing drug in U.S. in 2024 (for business reasons)
- Same total daily Detemir dose may be used when converting to other long acting agent
- May switch from Detemir total daily dose to any U-100 long acting Insulin (Lantus, Basaglar, Semglee)
- May also switch to the U-100 formulation of Insulin Degludec (Tresiba)
- Reduce total daily dose by 20% if patient at higher risk for Hypoglycemia
- (2024) Presc Lett 31(1): 4
IV. Medications: U-300
- Insulin Glargine U-300 (Toujeo, Toujeo Max Solostar)
- Toujeo Solostar pen
- Toujeo contains 80 u/injection (450 u/pen)
- Toujeo Max contains 160 u/injection (900 u/pen)
- Both contain the same 3x Glargine Insulin concentration of Lantus)
- Released in 2015 (curiously as Lantus becomes generic)
- Promoted as a longer acting Lantus (closer to 24 hour duration)
- However, more expensive ($500/month if 60 u/day); contrast with NPH at 10% of cost
- Do not adjust Toujeo dose more often than every 3-4 days
- Transitioning from other agents
- From Lantus, Basaglar daily
- Dose Toujeo at 110% of Lantus dose
- From Lantus twice daily
- Dose Toujeo at 100% of the Lantus dose
- From Detemir or NPH twice daily
- Dose Toujeo at 80% of total daily basal Insulin dose
- From Lantus, Basaglar daily
- Transitioning to other agents
- To Lantus or Basaglar
- Dose Lantus or Basaglar at 80% of Toujeo dose to start, then titrate up
- To Lantus or Basaglar
- References
- (2018) Presc Lett 25(8)
- Riddle (2014) Diabetes Care 37(10):2755-62 +PMID:25078900 [PubMed]
- Toujeo Solostar pen
V. Pharmacokinetics: Insulin Glargine (Lantus)
- Onset: 1 hour
- Duration: 21 to 24 hours
- May require divided dosing bid to maintain basal rate
- Peak: No peak
- Flat action profile throughout duration
- Mimics continuous Insulin Infusion
VI. Adverse effects
- Less nocturnal Hypoglycemia than other Insulins
- Lower post-prandial Glucose
VII. Dosing: Insulin Glargine (Lantus)
- Starting dose (no prior Insulin)
- Hemoglobin A1C <8%: 0.1 units/kg
- Hemoglobin A1C >8-10%: 0.2 units/kg
- Hemoglobin A1C >10%: 0.3 units/kg
- Old regimen for starting dose (use units/kg as above instead)
- Type I Diabetes: 10 Units at bedtime
- Type II Diabetes: 10-14 Units at bedtime
- Conversion from other long-acting Insulin
- NPH/ultralente qhs: start Lantus at same dose
- Consider starting Lantus at 80% of prior NPH dose
- NPH bid: Start Lantus at 80% of total daily NPH dose
- NPH/ultralente qhs: start Lantus at same dose
- Adjustment based on Fasting plasma Glucose (FPG)
- Typical adjustment is 1 to 2 units (or 5 to 10%) once to twice weekly
- Protocol 1
- FPG <70 mg/dl for 3 days: Decrease Lantus 1-2 units
- FPG 140-250 for 3 days: Increase Lantus 2-4 units
- FPG >250 for 3 days: Increase Lantus 4-8 units
- Protocol 2
- FPG <80 for 3 days: Decrease Lantus by 2 units
- FPG 100-120 for 3 days: Increase Lantus by 2 units
- FPG 120-140 for 3 days: Increase Lantus by 4 units
- FPG 140-180 for 3 days: Increase Lantus by 6 units
- FPG >180 for 3 days: Increase Lantus by 8 units
- Timing of dose for Lantus
- Studies gave Lantus at bedtime to avoid confusion
- Lantus is most effective if given in the morning
VIII. Preparations: Delivery Devices - OptiClik Pen
- Pens are free from Aventis
- Phone: 800-207-8049
- Pens ease Insulin delivery
- Lantus in cartridges costs 2 cents/unit more than vial
- (2005) Prescriber's Letter 12:32
Images: Related links to external sites (from Bing)
Related Studies
insulin glargine (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
INSULIN GLARGINE 100 UNIT/ML VIAL | Generic | $10.88 per ml |
INSULIN GLARGINE SOLOSTAR U100 | Generic | $10.87 per ml |
INSULIN GLARGINE-YFGN U100 PEN | Generic | $9.50 per ml |
INSULIN GLARGINE-YFGN U100 VL | Generic | $9.49 per ml |
lantus (on 4/20/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
LANTUS 100 UNIT/ML VIAL | $27.23 per ml | |
LANTUS SOLOSTAR 100 UNIT/ML | $27.23 per ml | |
levemir (on 4/20/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
LEVEMIR 100 UNIT/ML VIAL | $29.55 per ml | |
LEVEMIR FLEXPEN 100 UNIT/ML | $29.56 per ml | |
LEVEMIR FLEXTOUCH 100 UNIT/ML | $29.58 per ml | |
toujeo (on 4/20/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
TOUJEO MAX SOLOSTR 300 UNIT/ML | $82.96 per ml | |
TOUJEO SOLOSTAR 300 UNIT/ML | $82.93 per ml | |
insulin degludec (on 1/18/2023 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
INSULIN DEGLUDEC FLEXTOUCH 100 UNIT/ML PEN | Generic | $11.34 per ml |
INSULIN DEGLUDEC FLEXTOUCH 200 UNIT/ML PEN | Generic | $22.71 per ml |
tresiba (on 4/20/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
TRESIBA 100 UNIT/ML VIAL | $32.65 per ml | |
TRESIBA FLEXTOUCH 100 UNIT/ML | $32.55 per ml | |
TRESIBA FLEXTOUCH 200 UNIT/ML | $65.09 per ml | |
basaglar (on 2/23/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
BASAGLAR 100 UNIT/ML KWIKPEN | $20.93 per ml | |
BASAGLAR TEMPO PEN 100 UNIT/ML | $20.93 per ml | |
semglee (on 3/23/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
SEMGLEE (YFGN) 100 UNIT/ML PEN | $25.86 per ml | |
SEMGLEE (YFGN) 100 UNIT/ML VL | $25.83 per ml |